HRP20180124T1 - Glikozaminoglikani koji nisu antikoagulanti koji sadrže ponavljajuću jedinicu disaharida i njihova medicinska upotreba - Google Patents

Glikozaminoglikani koji nisu antikoagulanti koji sadrže ponavljajuću jedinicu disaharida i njihova medicinska upotreba Download PDF

Info

Publication number
HRP20180124T1
HRP20180124T1 HRP20180124TT HRP20180124T HRP20180124T1 HR P20180124 T1 HRP20180124 T1 HR P20180124T1 HR P20180124T T HRP20180124T T HR P20180124TT HR P20180124 T HRP20180124 T HR P20180124T HR P20180124 T1 HRP20180124 T1 HR P20180124T1
Authority
HR
Croatia
Prior art keywords
chemically modified
glycosaminoglycan
hours
heparin
kda
Prior art date
Application number
HRP20180124TT
Other languages
English (en)
Croatian (hr)
Inventor
Hans-Peter Ekre
Per-Olov ERIKSSON
Ulf Lindahl
Erik Holmer
Original Assignee
Dilafor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48668970&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20180124(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dilafor Ab filed Critical Dilafor Ab
Publication of HRP20180124T1 publication Critical patent/HRP20180124T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HRP20180124TT 2011-12-19 2012-12-19 Glikozaminoglikani koji nisu antikoagulanti koji sadrže ponavljajuću jedinicu disaharida i njihova medicinska upotreba HRP20180124T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161577223P 2011-12-19 2011-12-19
PCT/SE2012/051433 WO2013095279A1 (en) 2011-12-19 2012-12-19 Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use
EP12858809.2A EP2794665B1 (en) 2011-12-19 2012-12-19 Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use

Publications (1)

Publication Number Publication Date
HRP20180124T1 true HRP20180124T1 (hr) 2018-02-23

Family

ID=48668970

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20180124TT HRP20180124T1 (hr) 2011-12-19 2012-12-19 Glikozaminoglikani koji nisu antikoagulanti koji sadrže ponavljajuću jedinicu disaharida i njihova medicinska upotreba

Country Status (28)

Country Link
US (1) US9475888B2 (https=)
EP (1) EP2794665B1 (https=)
JP (2) JP6543467B2 (https=)
KR (1) KR102135485B1 (https=)
CN (1) CN104144950B (https=)
AU (1) AU2012354229B2 (https=)
BR (1) BR112014014454B1 (https=)
CA (1) CA2856492C (https=)
CL (1) CL2014001651A1 (https=)
CO (1) CO7061069A2 (https=)
CY (1) CY1119899T1 (https=)
DK (1) DK2794665T3 (https=)
ES (1) ES2656613T3 (https=)
HR (1) HRP20180124T1 (https=)
HU (1) HUE036523T2 (https=)
IL (1) IL232905A (https=)
LT (1) LT2794665T (https=)
ME (1) ME02994B (https=)
MX (1) MX351104B (https=)
NO (1) NO2904345T3 (https=)
PL (1) PL2794665T3 (https=)
PT (1) PT2794665T (https=)
RS (1) RS56874B1 (https=)
RU (1) RU2617764C2 (https=)
SI (1) SI2794665T1 (https=)
SM (1) SMT201800143T1 (https=)
WO (1) WO2013095279A1 (https=)
ZA (1) ZA201403640B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
HK1203370A1 (en) * 2012-03-26 2015-10-30 迪乐方有限责任公司 Method for treatment of labor arrest
HK1203369A1 (en) * 2012-03-26 2015-10-30 迪乐方有限责任公司 Combination treatment comprising sulphated glycosaminoglycans for inducing labor
JP2015516415A (ja) * 2012-05-08 2015-06-11 ディラフォール・アクチボラゲットＤｉｌａｆｏｒ Ａｂ 化学修飾ヘパリンまたはヘパラン硫酸および子宮収縮剤を用いた分娩後出血の処置
GB2515315A (en) * 2013-06-19 2014-12-24 Dilafor Ab New Processes
CN103788222B (zh) * 2014-01-08 2016-08-31 中国科学院昆明植物研究所 Fuc3S4S取代的低聚糖胺聚糖及其制备方法
MX2016014202A (es) * 2014-04-30 2017-05-03 Agency Science Tech & Res Sulfatos de heparan.
CN108424474B (zh) * 2017-02-15 2023-07-25 清华大学 去抗凝肝素衍生物及其用于炎症性肠病的治疗
JP7621366B2 (ja) * 2020-02-17 2025-01-24 ディラフォール アクチエボラグ 子癇前症の処置のためのタフォキシパリン
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin
AU2023266079A1 (en) 2022-05-03 2024-10-31 Dilafor Ab New medical use of tafoxiparin
GB202407366D0 (en) * 2024-05-23 2024-07-10 Glycos Biomedical Ltd Preparation of medium molecular weight heparin

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1136620A (en) 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
JPS63246396A (ja) * 1987-03-31 1988-10-13 Shiseido Co Ltd モノクロ−ナル抗体
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
SE9002550D0 (sv) * 1990-08-01 1990-08-01 Kabivitrum Ab Heparinfragment
SE9003181D0 (sv) 1990-10-04 1990-10-04 Kabivitrum Ab Use of heparin fraction
US5250519A (en) 1991-03-29 1993-10-05 Glycomed Incorporated Non-anticoagulant heparin derivatives
US5280016A (en) 1991-03-29 1994-01-18 Glycomed Incorporated Non-anticoagulant heparin derivatives
JPH0532703A (ja) * 1991-07-26 1993-02-09 Terumo Corp 低分子量ヘパリン誘導体の製造法
WO1994008595A1 (en) * 1992-10-13 1994-04-28 Virginia Commonwealth University Use of non-anticoagulant heparin for treating ischemia/reperfusion injury
US5527785A (en) 1993-05-14 1996-06-18 The Regents Of The University Of California Selectin receptor modulating compositions
EP0735050B1 (en) * 1995-03-31 2002-09-25 Hamilton Civic Hospitals Research Development, Inc. Compositions for inhibiting thrombogenesis
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5993810A (en) 1996-03-15 1999-11-30 Lebovitz; Shamir Israel Method of softening or ripening the cervix of a female mammal using collagenase
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
AU4572797A (en) 1996-10-15 1998-05-11 Toray Industries, Inc. Cervical canal maturing agent
GB9711443D0 (en) * 1997-06-03 1997-07-30 Leo Pharm Prod Ltd Chemical suppositions
WO1999026984A1 (fr) * 1997-11-20 1999-06-03 Ikuo Yamashina Modification de l'heparine de faible masse moleculaire et remede contre l'ulcere de la peau
US6596705B1 (en) 1998-02-09 2003-07-22 The Regents Of The University Of California Inhibition of L-selectin and P-selection mediated binding using heparin
US6498246B1 (en) 1998-02-26 2002-12-24 Seikagaku Corporation Glycosaminoglycan derivatives and processes for preparing same
US6028061A (en) 1998-06-18 2000-02-22 Children's Medical Center Corp Angiogenesis inhibitors and use thereof
WO2000006608A1 (en) * 1998-07-31 2000-02-10 Seikagaku Corporation Novel glycosaminoglycan and drug compositions containing the same
MXPA01002022A (es) * 1998-08-26 2002-04-24 Collaborative Group Ltd Receptor para beta-(1,3-)glucano soluble acuoso, no derivado.
CA2377734A1 (en) * 1999-06-30 2001-01-11 Hamilton Civic Hospitals Research Development, Inc. Heparin compositions that inhibit clot associated coagulation factors
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物
IT1316986B1 (it) 2000-01-25 2003-05-26 Sigma Tau Ind Farmaceuti Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
JP4585072B2 (ja) * 2000-02-29 2010-11-24 扶桑薬品工業株式会社 ヘパリン解重合法、解重合ヘパリン、その誘導体および医薬組成物
DE60138115D1 (de) * 2000-09-12 2009-05-07 Massachusetts Inst Technology Verfahren und produkte, die mit niedermolekularem heparin assoziiert sind
SE521676C2 (sv) 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
EP1542704A1 (en) 2002-04-18 2005-06-22 Stephen H. Embury Method and composition for preventing pain in sickle cell patients
US8071569B2 (en) 2002-09-20 2011-12-06 Mousa Shaker A Oxidized heparin fractions and their use in inhibiting angiogenesis
JP2005106694A (ja) * 2003-09-30 2005-04-21 Mochida Pharmaceut Co Ltd 敗血症早期検出及び重篤度評価
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
US20060040896A1 (en) * 2004-08-18 2006-02-23 Paringenix, Inc. Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity
US7741311B2 (en) 2005-01-03 2010-06-22 Shaker Mousa Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing
US20080214480A1 (en) 2005-07-22 2008-09-04 Trf Pharma, Inc. Method for Treating Sickle Cell Disease and Sickle Cell Disease Sequalae
ZA200801696B (en) * 2005-07-22 2009-08-26 Univ California Heparin compositions and selection inhibition
CA2648385C (en) * 2006-04-04 2020-09-01 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
CN101495517B (zh) * 2006-05-25 2012-10-10 莫曼塔医药品有限公司 低分子量肝素及其用途
WO2009007224A1 (en) * 2007-07-10 2009-01-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Low molecular weight heparin derivatives having neuroprotective activity
US8592393B2 (en) * 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
EP2207811B1 (en) * 2007-11-02 2017-01-04 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
ES2567079T3 (es) 2007-11-02 2016-04-19 Momenta Pharmaceuticals, Inc. Composiciones de polisacáridos que no son anticoagulantes
WO2009073184A1 (en) 2007-12-03 2009-06-11 Florida State University Research Foundation, Inc. Compositions for inducing labor and associated methods
CA2719666C (en) 2008-04-04 2016-08-16 Glenn Prestwich Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
WO2010111570A1 (en) * 2009-03-27 2010-09-30 E. I. Du Pont De Nemours And Company Polyglycerol aldehydes
AU2010236222B2 (en) 2009-04-16 2015-10-15 Momenta Pharmaceuticals, Inc. Methods of assessing activity of a polysaccharide composition
AU2010268756A1 (en) 2009-06-30 2012-01-19 The Walter And Eliza Hall Institute Of Medical Research Sulfated polysaccharides having antiplasmodial activity and methods and products for identifying antiplasmodial activity
EP2461821A4 (en) * 2009-07-31 2013-07-03 Bayer Healthcare Llc MODIFIED POLYPEPTIDES OF FACTOR IX AND USES THEREOF
US9066991B2 (en) * 2009-12-22 2015-06-30 Lifebond Ltd. Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
HK1203370A1 (en) 2012-03-26 2015-10-30 迪乐方有限责任公司 Method for treatment of labor arrest
HK1203369A1 (en) 2012-03-26 2015-10-30 迪乐方有限责任公司 Combination treatment comprising sulphated glycosaminoglycans for inducing labor

Also Published As

Publication number Publication date
ZA201403640B (en) 2017-06-28
SI2794665T1 (en) 2018-03-30
JP2015500388A (ja) 2015-01-05
CO7061069A2 (es) 2014-09-19
BR112014014454B1 (pt) 2021-03-09
NO2904345T3 (https=) 2018-07-21
CN104144950B (zh) 2017-09-05
EP2794665A4 (en) 2015-08-26
DK2794665T3 (da) 2018-01-29
RS56874B1 (sr) 2018-04-30
MX2014007122A (es) 2015-03-05
JP2018111825A (ja) 2018-07-19
CL2014001651A1 (es) 2014-10-10
SMT201800143T1 (it) 2018-05-02
EP2794665B1 (en) 2017-11-22
US9475888B2 (en) 2016-10-25
JP6543467B2 (ja) 2019-07-10
BR112014014454A2 (pt) 2017-06-13
HUE036523T2 (hu) 2018-07-30
EP2794665A1 (en) 2014-10-29
CN104144950A (zh) 2014-11-12
MX351104B (es) 2017-10-02
AU2012354229B2 (en) 2016-12-01
WO2013095279A1 (en) 2013-06-27
LT2794665T (lt) 2017-12-27
AU2012354229A1 (en) 2014-06-05
RU2014129816A (ru) 2016-02-20
PT2794665T (pt) 2018-01-24
CA2856492C (en) 2017-01-10
PL2794665T3 (pl) 2018-04-30
IL232905A (en) 2017-02-28
CA2856492A1 (en) 2013-06-27
RU2617764C2 (ru) 2017-04-26
ME02994B (me) 2018-10-20
KR102135485B1 (ko) 2020-07-17
KR20140113652A (ko) 2014-09-24
IL232905A0 (en) 2014-07-31
HK1202883A1 (en) 2015-10-09
CY1119899T1 (el) 2018-06-27
ES2656613T3 (es) 2018-02-27
US20150011505A1 (en) 2015-01-08

Similar Documents

Publication Publication Date Title
HRP20180124T1 (hr) Glikozaminoglikani koji nisu antikoagulanti koji sadrže ponavljajuću jedinicu disaharida i njihova medicinska upotreba
Wang et al. Chemical composition and moisture-absorption/retention ability of polysaccharides extracted from five algae
CY1112808T1 (el) Μειγματα ολιγοσακχαριτων προερχομενων απο την ηπαρινη, η παρασκευη τους και φαρμακευτικες συνθεσεις που τα περιεχουν
Smestad Paulsen Biologically active polysaccharides as possible lead compounds
JP2015500388A5 (https=)
Ciancia et al. Overview of anticoagulant activity of sulfated polysaccharides from seaweeds in relation to their structures, focusing on those of green seaweeds
CZ307433B6 (cs) Deriváty částečně desulfátovaných glykosaminoglykanů jako inhibitory heparanázy mající antiangiogenní účinky a zabraňující antikoagulačnímu působení
Zhao et al. Preparation of low-molecular-weight polyguluronate sulfate and its anticoagulant and anti-inflammatory activities
Krylov et al. Acid-promoted synthesis of per-O-sulfated fucooligosaccharides related to fucoidan fragments
Revuelta et al. Heparanized chitosans: towards the third generation of chitinous biomaterials
HRP20230820T1 (hr) Heparan-sulfat, s visokom stopom 3-o-sulfatiranja u glukozaminskim ostacima
Song et al. Seaweed-derived fucoidans and rhamnan sulfates serve as potent anti-SARS-CoV-2 agents with potential for prophylaxis
DK3063177T3 (en) DERIVATIVES OF N-DESULPHATED GLYCOSAMINOGLYCANES AND USE AS MEDICINES
JPH10218902A5 (https=)
EP1745705A1 (en) Process for preparing uronic acid oligosaccharides by extrusion
JP6784454B2 (ja) グリコサミノグリカンのカルボキシル化誘導体、及び薬物としての使用
RU2014149230A (ru) Лечение послеродового кровотечения (прк)
Bisio et al. Carbohydrate‐Based Antithrombotics
CN115485308A (zh) 制备低分子量肝素的方法以及由此获得的低分子量肝素
Driguez Synthesis of Natural and Nonnatural Heparin Fragments: Optimizations and Applications toward Modulation of FGF2‐Mediated FGFR Signaling
HK40004031A (en) Derivatives of n-desulfated glycosaminoglycans and use as drugs
Song et al. In Vitro and In Vivo Degradation Behaviors of Acetylated Chitosan Porous Beads
Li et al. an der, & Codee,. DC (2021). S nthesis of uronic acid containing oligosaccharides. In... Barchi (Ed.),(pp. 200-227). Else ier. doi: 10.1016
ITMI20071926A1 (it) Frazioni di eparina ottenute con processo di depolimerizzazione integrato, dotate di nuove attivita' biologiche e processo per la loro preparazione